ClinicalTrials.gg
Not yet recruitingNCT06395207Updated May 2, 2024

A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra Leone

An interventional study of Proactive community case management and Strengthened SBCC and stock out mitigation in Health Services Research, sponsored by PATH. Not yet recruiting. Per ClinicalTrials.gov, last updated 2024-05-02.

Sponsored by PATH · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
9,000
Allocation
Randomized
Sex
All
01

Study summary

This is a three arm cluster randomized control trial to determine if proactive community case management (ProCCM) conducted over a short period of time improves care-seeking indicators for febrile illnesses in children in hard to reach (HTR) areas of Sierra Leone compared to integrated community case management (iCCM). The three arms include:

  1. Optimized standard of care for CCM plus ProCCM - ProCCM will be implemented for two months near the start of the transmission season, and the existing program will be supplemented to ensure that HTR CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed.
  2. Optimized standard of care- as in arm 1 without ProCCM
  3. Routine implementation (control) - no changes (business as usual) to iCCM, SBCC and stock management.
02

Conditions studied

  • Health Services Research
03

In context

Lead sponsor

PATH is the lead sponsor of 113 studies on the registry; 7 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 10 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Household lives within the study cluster
  • Head of household or a household member over the age of 18 provides verbal consent for the HTR CHW visit
  • All available household members at the time of the HTR CHW visits are eligible to receive services

Exclusion criteria

Exclusion Criteria:

  • Household does not live within the study cluster
  • Household does not provide consent for the study visit
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
9,000 participants (estimated)

Study arms

  • Experimental
    Optimized standard of care for CCM plus ProCCM

    ProCCM will be implemented for two months near the start of the transmission season, and the existing program will be supplemented to ensure that HTR CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed.

    Behavioral: Proactive community case management

  • Active comparator
    Standard of care

    As in arm 1 without ProCCM

    Behavioral: Strengthened SBCC and stock out mitigation

  • No intervention
    Routine implementation (control)

    No changes (business as usual) to iCCM, SBCC and stock management.

Interventions

  • BehavioralProactive community case management

    Community health workers conduct proactive visits to households in their community every two weeks for two months to screen for fever and test and treat febrile individuals for malaria.

  • BehavioralStrengthened SBCC and stock out mitigation

    Ensure CHWs have all commodities needed for malaria testing and treatment and are adequately trained on SBCC messages to ensure activities are implemented as designed in the national strategy.

06

What researchers measure

Primary outcomes

  1. The proportion of children under five years of age with recent fever (within the past two weeks) who sought care from a CHW or public health facility on the same day or day after fever onset

    Changes in care seeking will be assessed through three cross-sectional surveys. A baseline survey will be conducted prior to intervention implementation followed by a second survey at or near the end of the ProCCM intervention period and a final survey at the end of the malaria transmission season.

    Time frame: Cross sectional collected immediately post-intervention and 5 months post-intervention

Secondary outcomes

  1. Cost per additional fever case promptly seeking care at qualified provider

    Using project records and information from the cross-sectional surveys, the cost of delivering ProCCM, incremental SBCC and stockout management interventions will be determined with the incremental number of fever cases receiving prompt management by a qualified provider as the denominator.

    Time frame: 5 months post-intervention

  2. Barriers and enablers of care-seeking behavior for febrile illness of people of all ages and how ProCCM impacts this behavior explored through focus groups

    Focus group discussions will be held with community members post-intervention to assess barriers and enablers of care-seeking for febrile illness among people of all ages and how ProCCM impacts this behavior as reported by community members

    Time frame: End of the malaria transmission season which will be 2 months post intervention

  3. Perceptions of the availability, cost, quality, and ease of seeking care for febrile illness explored through focus groups and in-depth interviews with community members.

    Focus group discussions and in-depth interviews will be held with community members to explore their perception of the intervention and how it impacts their sense of the availability, cost, quality, and ease of seeking care for febrile illness.

    Time frame: End of the malaria transmission season which will be 2 months post intervention

  4. Job satisfaction and perceived workload as described by CHWs during focus groups and interviews

    Focus groups and in-depth interviews will be conducted with community health workers to explore their job satisfaction and perceived workload as it relates to the intervention.

    Time frame: End of the malaria transmission season which will be 2 months post intervention

  5. Differences in touchpoints and connection between CHWs and health facility staff as described through qualitative analysis.

    In-depth interviews will be conducted with health facility staff and peer supervisors to explore how the intervention influences their perceived linkages and touchpoints with CHWs.

    Time frame: End of the malaria transmission season which will be 2 months post intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2024; primary completion for Mar 2025, 10 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2024
First posted
May 2, 2024
StartEst.
May 6, 2024
Primary completionEst.
Mar 30, 2025
CompletionEst.
Mar 30, 2025
Last update
May 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06395207
Lead sponsor
PATH
Collaborators
Tulane University, Sustainable Health Systems Sierra Leone
Responsible party
Sponsor
First posted
May 2, 2024
Start date
May 6, 2024 (estimated)
Primary completion
Mar 30, 2025 (estimated)
Completion
Mar 30, 2025 (estimated)
Last update
May 2, 2024

Study contacts

Annie Arnzen, MPH
Contact
aarnzen@path.org
978-806-5837
Megan Littrell, PhD
Contact
mlittrell@path.org

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion